Literature DB >> 3093581

Isotype concentrations of human antibodies to group A meningococcal polysaccharide.

N Rautonen, J Pelkonen, S Sipinen, H Käyhty, O Mäkelä.   

Abstract

Antibodies to meningococcal group A polysaccharide (MenA) in the sera of 34 vaccinated adults were quantitated by an isotype-resolving solid-phase RIA (IgA, IgM, IgG1, IgG2, IgG3, and IgG4). All individuals had antibodies before vaccination. The geometric mean concentration was 2.9 micrograms/ml. Two weeks after vaccination the mean antibody concentration had trebled. Average proportions of the three isotypes were then as follows: IgA 15%, IgM 48%, IgG 37%. No differences were found between individuals who had been immunized with the polysaccharide 7 to 8 yr earlier and "primary responders." The subclass composition of IgG antibodies was determined in the 24 postvaccination samples with a definite IgG response (greater than 2-fold increase). IgG1 was the predominant subclass in antibodies of some sera and IgG2 in others, but the average proportions of both subclasses were nearly the same. IgG3 and IgG4 were only found in occasional sera, but when present, each subclass accounted for up to 6%. Although the ratio of kappa and lambda chains could not be determined, there was evidence to suggest that it was higher in anti-MenA antibodies than in antibodies to protein antigens.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3093581

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  13 in total

1.  Immunoglobulin G subclass response to a meningococcal quadrivalent polysaccharide-diphtheria toxoid conjugate vaccine.

Authors:  Helen Findlow; Jo Southern; Lesley Mabey; Paul Balmer; Robert S Heyderman; Cressida Auckland; Rhonwen Morris; Elizabeth Miller; Ray Borrow
Journal:  Clin Vaccine Immunol       Date:  2006-04

2.  Human immunoglobulin G2 (IgG2) and IgG4, but not IgG1 or IgG3, protect mice against Cryptococcus neoformans infection.

Authors:  David O Beenhouwer; Esther M Yoo; Chun-Wei Lai; Miguel A Rocha; Sherie L Morrison
Journal:  Infect Immun       Date:  2007-01-12       Impact factor: 3.441

3.  Subclass restriction of human enterovirus antibodies.

Authors:  E G Torfason; C B Reimer; H L Keyserling
Journal:  J Clin Microbiol       Date:  1987-08       Impact factor: 5.948

4.  Human nasopharyngeal-associated lymphoreticular tissues. Functional analysis of subepithelial and intraepithelial B and T cells from adenoids and tonsils.

Authors:  P N Boyaka; P F Wright; M Marinaro; H Kiyono; J E Johnson; R A Gonzales; M R Ikizler; J A Werkhaven; R J Jackson; K Fujihashi; S Di Fabio; H F Staats; J R McGhee
Journal:  Am J Pathol       Date:  2000-12       Impact factor: 4.307

5.  Influence of the G2m(n) allotype and age on IgG subclass distribution in antibodies to dietary proteins in children with coeliac disease.

Authors:  N Rautonen; J Rautonen; E Savilahti
Journal:  Clin Exp Immunol       Date:  1990-08       Impact factor: 4.330

Review 6.  Selective IgG subclass deficiency: quantification and clinical relevance.

Authors:  R Jefferis; D S Kumararatne
Journal:  Clin Exp Immunol       Date:  1990-09       Impact factor: 4.330

7.  Development of serum antibodies of the immunoglobulin G class and subclasses against the capsular polysaccharide of Haemophilus influenzae type b in children and adults with invasive infections.

Authors:  B A Claesson; T Lagergård; B Trollfors
Journal:  J Clin Microbiol       Date:  1988-12       Impact factor: 5.948

8.  Heavy-chain isotype patterns of human antibody-secreting cells induced by Haemophilus influenzae type b conjugate vaccines in relation to age and preimmunity.

Authors:  T Barington; L Juul; A Gyhrs; C Heilmann
Journal:  Infect Immun       Date:  1994-08       Impact factor: 3.441

9.  Proportions of immunoglobulin isotypes in paralytic poliomyelitis and after vaccination.

Authors:  I Julkunen; P Ukkonen; M Stenvik; T Hovi; L Renkonen; O Mäkelä
Journal:  J Clin Immunol       Date:  1987-07       Impact factor: 8.317

10.  Sin nombre virus (SNV) Ig isotype antibody response during acute and convalescent phases of hantavirus pulmonary syndrome.

Authors:  P Bostik; J Winter; T G Ksiazek; P E Rollin; F Villinger; S R Zaki; C J Peters; A A Ansari
Journal:  Emerg Infect Dis       Date:  2000 Mar-Apr       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.